Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Multiple Myeloma
100%
Medication Adherence
100%
Oral Anticancer Drugs
100%
Comorbid Chronic Conditions
100%
Medication Use
33%
First Year
22%
Proportion of Days Covered
22%
Medicare
11%
Medicare Claims Data
11%
Chronic Conditions
11%
Comorbid
11%
Retrospective Cohort Study
11%
Multiple Chronic Conditions
11%
Treatment Regimen
11%
Comorbid Conditions
11%
Antihypertensive Therapy
11%
Wilcoxon Signed-rank Test
11%
Medicaid Patients
11%
McNemar Test
11%
Adjusted Analysis
11%
Prescription Refill
11%
Complex Treatment
11%
Non-adherent
11%
Oncolytic Therapy
11%
Commercial Claims
11%
Difference-in-differences Model
11%
Medicine and Dentistry
Anticarcinogen
100%
Multiple Myeloma
100%
Medication Compliance
100%
Oral
100%
Anticancer Drug
88%
Medicare
33%
Antihypertensive Therapy
11%
Retrospective Cohort Study
11%
Multiple Chronic Conditions
11%
McNemar Test
11%
Wilcoxon Signed Ranks Test
11%
Nursing and Health Professions
Medication Compliance
100%
Anticarcinogen
100%
Multiple Myeloma
100%
Anticancer
100%
Medicare
37%
Adherence
37%
Cohort Analysis
12%
Multiple Chronic Conditions
12%
Antihypertensive Therapy
12%
Wilcoxon Signed Ranks Test
12%
McNemar Test
12%
Pharmacology, Toxicology and Pharmaceutical Science
Anticarcinogen
100%
Multiple Myeloma
100%
Anticancer Drug
100%
Cohort Study
12%
Antihypertensive Therapy
12%
Multiple Chronic Conditions
12%